Crossmark

Exploring the Therapeutic Potential of Scorpion-Derived Css54 Peptide Against Candida albicans

Published Online: 2024-04-08

Published Print: 2024-02

Authors

Park, Jonggwan

Kim, Hyeongsun

Kang, Da Dam

Park, Yoonkyung https://orcid.org/0000-0002-8717-3080
Funding

Funding for this research was provided by:

National Research Foundation of Korea (NRF-2021R1C1C2009855)

National Research Foundation of Korea (NRF-2017M3A9E4077206)

National Research Foundation of Korea (2023R1A2C3006368)

National Research Foundation of Korea (RS-2023-00228746)

Institute for Information and Communications Technology Promotion (MSIT No. 2017-0-01714)
License Information

Text and Data Mining valid from 2024-02-01

Version of Record valid from 2024-04-08
More Information

Article History

Received: 19 December 2023

Revised: 23 January 2024

Accepted: 23 January 2024

First Online: 8 April 2024

Declarations

:

: The authors declare no conflict of interest.

Document is current